-+ 0.00%
-+ 0.00%
-+ 0.00%

TransMedics rilis presentasi soal teknologi perfusi organ portabel dan jaringan layanan-logistik transplantasi nasional

PUBT·08/11/2026 20:31:26
Listen to the news
TransMedics rilis presentasi soal teknologi perfusi organ portabel dan jaringan layanan-logistik transplantasi nasional
  • Transmedics Group Inc. menegaskan strategi memperluas pemanfaatan organ transplant lewat platform perfusi hangat portabel OCS dan jaringan layanan NOP.
  • Pendapatan naik menjadi USD 605 juta pada FY25 dari USD 94 juta pada FY22; CAGR pendapatan FY22–FY25 sebesar 86%.
  • Laba operasi disesuaikan berbalik positif menjadi USD 112,2 juta pada FY25; FY24 USD 37 juta, FY23 rugi USD 29 juta.
  • Perusahaan memandu pendapatan FY26 USD 737–757 juta, setara pertumbuhan 22–25%.
  • Kas dan setara kas tercatat USD 472,7 juta per 30 Juni 2026; fokus pertumbuhan mencakup OCS Kidney, ekspansi Eropa, dan OCS 3.0.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.